2 results
Approved WMOPending
Reducing postoperative pain and nausea improves patient satisfaction.
Approved WMOPending
The primary objective is to determine the efficacy of the neuroprotectant, nerinetide in:• Reducing global disability in participants with acute ischemic stroke (AIS)